Daniel Barenboim, Parkinson's disease
Conductor Daniel Barenboim says he's been diagnosed with Parkinson's disease
Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday on Instagram. He has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner’s Ring Cycle in Berlin.
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
19hon MSN
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Hosted on MSN19m
Ozzy Osbourne admits he 'can't walk' as he delivers worrying Parkinson's update ahead of Black Sabbath reunionOzzy Osbourne has revealed he can no longer walk as his battle with Parkinson's disease continues to progress. The 76-year-old rock legend made the admission during his SiriusXM radio show. "I have ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback